The global Implantable Neurostimulation Devices market size was valued at US$ 6159 million in 2024 and is forecast to a readjusted size of USD 11890 million by 2031 with a CAGR of 10.0% during review period.
Neurostimulation devices are implantable devices that help in the therapeutic activation of the nervous systems. These devices deliver electrical stimulation to the brain and nervous systems for the treatment of various types of neurological disorders such as pain, epilepsy, Parkinson's disease, depression, obsessive-compulsive disorder, dystonia, and tremors. These devices target specific areas of the brain or spinal cord by blocking the pain messages before they reach the brain.
The Implantable Neurostimulation Devices market is primarily driven by the rising prevalence of neurological disorders such as Parkinson's disease, epilepsy, chronic pain, and depression. As the global population ages, the incidence of these chronic conditions is increasing, creating a growing demand for effective and long-term treatment options. Implantable neurostimulators offer a promising solution for managing symptoms of these conditions, particularly for patients who have not responded to conventional therapies. Technological advancements in neurostimulation devices, such as more refined targeting mechanisms, smaller device sizes, and enhanced patient control, are also fueling market growth by improving treatment outcomes and patient satisfaction.
However, the market faces several challenges, including the high cost of implantable devices and the associated surgical procedures. These costs can limit accessibility, especially in low- and middle-income countries or healthcare systems with budget constraints. Additionally, while neurostimulators have shown positive results in treating various conditions, concerns remain regarding the long-term effectiveness, potential side effects, and device-related complications, such as battery life and the need for device replacements. The complexity of implantation and post-operative care also presents challenges for healthcare providers, requiring specialized training and resources, which may hinder broader adoption.
North America is the largest sales region of implantable neurostimulation devices, with market share nearly 42% in 2023. Europe is the second largest sales of implantable neurostimulation devices, enjoying market share nearly 29% in 2023. Medtronic, Boston Scientific, Abbott, LivaNova are the leading company, with the market share about 90%.
This report is a detailed and comprehensive analysis for global Implantable Neurostimulation Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Implantable Neurostimulation Devices market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K USD/Unit), 2020-2031
Global Implantable Neurostimulation Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K USD/Unit), 2020-2031
Global Implantable Neurostimulation Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K USD/Unit), 2020-2031
Global Implantable Neurostimulation Devices market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Implantable Neurostimulation Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Implantable Neurostimulation Devices market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Boston Scientific, Abbott, LivaNova, Nevro, Ruishenan Medical, Beijing Pins, Sceneray, Inspire Medical Systems, Nurotron, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Implantable Neurostimulation Devices market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Spinal Cord Stimulation (SCS)
Gastric Electric Stimulation (GES)
Deep Brain Stimulation (DBS)
Sacral Nerve Stimulation (SNS)
Vagus Nerve Stimulation (VNS)
Others
麻豆原创 segment by Application
Parkinson鈥檚 Disease
Epilepsy
Pain Management
Other
Major players covered
Medtronic
Boston Scientific
Abbott
LivaNova
Nevro
Ruishenan Medical
Beijing Pins
Sceneray
Inspire Medical Systems
Nurotron
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Implantable Neurostimulation Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Implantable Neurostimulation Devices, with price, sales quantity, revenue, and global market share of Implantable Neurostimulation Devices from 2020 to 2025.
Chapter 3, the Implantable Neurostimulation Devices competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Implantable Neurostimulation Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Implantable Neurostimulation Devices market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Implantable Neurostimulation Devices.
Chapter 14 and 15, to describe Implantable Neurostimulation Devices sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Implantable Neurostimulation Devices Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Spinal Cord Stimulation (SCS)
1.3.3 Gastric Electric Stimulation (GES)
1.3.4 Deep Brain Stimulation (DBS)
1.3.5 Sacral Nerve Stimulation (SNS)
1.3.6 Vagus Nerve Stimulation (VNS)
1.3.7 Others
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Implantable Neurostimulation Devices Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Pain Management
1.4.3 Parkinson's Disease
1.4.4 Urinary and Fecal Incontinence
1.4.5 Epilepsy
1.4.6 Gastroparesis
1.4.7 Others
1.5 Global Implantable Neurostimulation Devices 麻豆原创 Size & Forecast
1.5.1 Global Implantable Neurostimulation Devices Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Implantable Neurostimulation Devices Sales Quantity (2020-2031)
1.5.3 Global Implantable Neurostimulation Devices Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Implantable Neurostimulation Devices Product and Services
2.1.4 Medtronic Implantable Neurostimulation Devices Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Medtronic Recent Developments/Updates
2.2 Boston Scientific
2.2.1 Boston Scientific Details
2.2.2 Boston Scientific Major Business
2.2.3 Boston Scientific Implantable Neurostimulation Devices Product and Services
2.2.4 Boston Scientific Implantable Neurostimulation Devices Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Boston Scientific Recent Developments/Updates
2.3 St. Jude Medical (Abbott)
2.3.1 St. Jude Medical (Abbott) Details
2.3.2 St. Jude Medical (Abbott) Major Business
2.3.3 St. Jude Medical (Abbott) Implantable Neurostimulation Devices Product and Services
2.3.4 St. Jude Medical (Abbott) Implantable Neurostimulation Devices Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 St. Jude Medical (Abbott) Recent Developments/Updates
2.4 LivaNova
2.4.1 LivaNova Details
2.4.2 LivaNova Major Business
2.4.3 LivaNova Implantable Neurostimulation Devices Product and Services
2.4.4 LivaNova Implantable Neurostimulation Devices Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 LivaNova Recent Developments/Updates
2.5 Nevro
2.5.1 Nevro Details
2.5.2 Nevro Major Business
2.5.3 Nevro Implantable Neurostimulation Devices Product and Services
2.5.4 Nevro Implantable Neurostimulation Devices Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Nevro Recent Developments/Updates
2.6 NeuroPace
2.6.1 NeuroPace Details
2.6.2 NeuroPace Major Business
2.6.3 NeuroPace Implantable Neurostimulation Devices Product and Services
2.6.4 NeuroPace Implantable Neurostimulation Devices Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 NeuroPace Recent Developments/Updates
2.7 Beijing Pins
2.7.1 Beijing Pins Details
2.7.2 Beijing Pins Major Business
2.7.3 Beijing Pins Implantable Neurostimulation Devices Product and Services
2.7.4 Beijing Pins Implantable Neurostimulation Devices Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Beijing Pins Recent Developments/Updates
2.8 Synapse Biomedical
2.8.1 Synapse Biomedical Details
2.8.2 Synapse Biomedical Major Business
2.8.3 Synapse Biomedical Implantable Neurostimulation Devices Product and Services
2.8.4 Synapse Biomedical Implantable Neurostimulation Devices Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Synapse Biomedical Recent Developments/Updates
3 Competitive Environment: Implantable Neurostimulation Devices by Manufacturer
3.1 Global Implantable Neurostimulation Devices Sales Quantity by Manufacturer (2020-2025)
3.2 Global Implantable Neurostimulation Devices Revenue by Manufacturer (2020-2025)
3.3 Global Implantable Neurostimulation Devices Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Implantable Neurostimulation Devices by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Implantable Neurostimulation Devices Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Implantable Neurostimulation Devices Manufacturer 麻豆原创 Share in 2024
3.5 Implantable Neurostimulation Devices 麻豆原创: Overall Company Footprint Analysis
3.5.1 Implantable Neurostimulation Devices 麻豆原创: Region Footprint
3.5.2 Implantable Neurostimulation Devices 麻豆原创: Company Product Type Footprint
3.5.3 Implantable Neurostimulation Devices 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Implantable Neurostimulation Devices 麻豆原创 Size by Region
4.1.1 Global Implantable Neurostimulation Devices Sales Quantity by Region (2020-2031)
4.1.2 Global Implantable Neurostimulation Devices Consumption Value by Region (2020-2031)
4.1.3 Global Implantable Neurostimulation Devices Average Price by Region (2020-2031)
4.2 North America Implantable Neurostimulation Devices Consumption Value (2020-2031)
4.3 Europe Implantable Neurostimulation Devices Consumption Value (2020-2031)
4.4 Asia-Pacific Implantable Neurostimulation Devices Consumption Value (2020-2031)
4.5 South America Implantable Neurostimulation Devices Consumption Value (2020-2031)
4.6 Middle East & Africa Implantable Neurostimulation Devices Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Implantable Neurostimulation Devices Sales Quantity by Type (2020-2031)
5.2 Global Implantable Neurostimulation Devices Consumption Value by Type (2020-2031)
5.3 Global Implantable Neurostimulation Devices Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Implantable Neurostimulation Devices Sales Quantity by Application (2020-2031)
6.2 Global Implantable Neurostimulation Devices Consumption Value by Application (2020-2031)
6.3 Global Implantable Neurostimulation Devices Average Price by Application (2020-2031)
7 North America
7.1 North America Implantable Neurostimulation Devices Sales Quantity by Type (2020-2031)
7.2 North America Implantable Neurostimulation Devices Sales Quantity by Application (2020-2031)
7.3 North America Implantable Neurostimulation Devices 麻豆原创 Size by Country
7.3.1 North America Implantable Neurostimulation Devices Sales Quantity by Country (2020-2031)
7.3.2 North America Implantable Neurostimulation Devices Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Implantable Neurostimulation Devices Sales Quantity by Type (2020-2031)
8.2 Europe Implantable Neurostimulation Devices Sales Quantity by Application (2020-2031)
8.3 Europe Implantable Neurostimulation Devices 麻豆原创 Size by Country
8.3.1 Europe Implantable Neurostimulation Devices Sales Quantity by Country (2020-2031)
8.3.2 Europe Implantable Neurostimulation Devices Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Implantable Neurostimulation Devices Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Implantable Neurostimulation Devices Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Implantable Neurostimulation Devices 麻豆原创 Size by Region
9.3.1 Asia-Pacific Implantable Neurostimulation Devices Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Implantable Neurostimulation Devices Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Implantable Neurostimulation Devices Sales Quantity by Type (2020-2031)
10.2 South America Implantable Neurostimulation Devices Sales Quantity by Application (2020-2031)
10.3 South America Implantable Neurostimulation Devices 麻豆原创 Size by Country
10.3.1 South America Implantable Neurostimulation Devices Sales Quantity by Country (2020-2031)
10.3.2 South America Implantable Neurostimulation Devices Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Implantable Neurostimulation Devices Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Implantable Neurostimulation Devices Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Implantable Neurostimulation Devices 麻豆原创 Size by Country
11.3.1 Middle East & Africa Implantable Neurostimulation Devices Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Implantable Neurostimulation Devices Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Implantable Neurostimulation Devices 麻豆原创 Drivers
12.2 Implantable Neurostimulation Devices 麻豆原创 Restraints
12.3 Implantable Neurostimulation Devices Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Implantable Neurostimulation Devices and Key Manufacturers
13.2 Manufacturing Costs Percentage of Implantable Neurostimulation Devices
13.3 Implantable Neurostimulation Devices Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Implantable Neurostimulation Devices Typical Distributors
14.3 Implantable Neurostimulation Devices Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Medtronic
Boston Scientific
Abbott
LivaNova
Nevro
Ruishenan Medical
Beijing Pins
Sceneray
Inspire Medical Systems
Nurotron
听
听
*If Applicable.
